» Articles » PMID: 37958932

Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Nov 14
PMID 37958932
Authors
Affiliations
Soon will be listed here.
Abstract

Cannabinoid receptors are expressed in human and animal trigeminal sensory neurons; however, the expression in the equine trigeminal ganglion is unknown. Ten trigeminal ganglia from five horses were collected post-mortem from an abattoir. The expression of cannabinoid receptors type 1 (CB1R) and type 2 (CB2R), and the cannabinoid-related receptors like transient receptor potential vanilloid type 1 (TRPV1), peroxisome proliferator-activated receptor gamma (PPARɣ), and G protein-related receptor 55 (GPR55) in the trigeminal ganglia (TG) of the horse were studied, using immunofluorescence on cryosections and formalin-fixed paraffin-embedded (FFPE) sections. Neurons and glial cells were identified using fluorescent Nissl staining NeuroTrace and an antibody directed against the glial marker glial fibrillary acidic protein (GFAP), respectively. Macrophages were identified by means of an antibody directed against the macrophages/microglia marker ionized calcium-binding adapter molecule 1 (IBA1). The protein expression of CB1R, CB2R, TRPV1, and PPARɣ was found in the majority of TG neurons in both cryosections and FFPE sections. The expression of GPR55 immunoreactivity was mainly detectable in FFPE sections, with expression in the majority of sensory neurons. Some receptors were also observed in glial cells (CB2R, TRPV1, PPARγ, and GPR55) and inflammatory cells (PPARγ and GPR55). These results support further investigation of such receptors in disorders of equine trigeminal neuronal excitability.

Citing Articles

Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review.

Di Salvo A, Chiaradia E, Sforna M, Rocca G Vet Res Commun. 2024; 48(5):2915-2941.

PMID: 39162768 PMC: 11442603. DOI: 10.1007/s11259-024-10509-7.

References
1.
Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I . Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience. 2000; 100(4):685-8. DOI: 10.1016/s0306-4522(00)00389-4. View

2.
Price T, Patwardhan A, Akopian A, Hargreaves K, Flores C . Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol. 2004; 141(7):1118-30. PMC: 1574881. DOI: 10.1038/sj.bjp.0705711. View

3.
Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin C, Brenner G . Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci. 2007; 10(7):870-9. PMC: 2234438. DOI: 10.1038/nn1916. View

4.
Vuckovic S, Srebro D, Savic Vujovic K, Vucetic C, Prostran M . Cannabinoids and Pain: New Insights From Old Molecules. Front Pharmacol. 2018; 9:1259. PMC: 6277878. DOI: 10.3389/fphar.2018.01259. View

5.
Hill K . Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. JAMA. 2015; 313(24):2474-83. DOI: 10.1001/jama.2015.6199. View